Israeli based life sciences, healthcare, and technology venture capital firm aMoon is on pace to reach its hard cap of $750 million for its second fund.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,